Registration for the second annual WIN Symposium on personalized cancer medicine is still open, with a preferential rate available until the 4th of July. This unique event, to be held on the 7th to 9th of July 2010 in the Palais des Congrès, Paris, will offer an unprecedented opportunity to discuss the latest advances in tailored cancer medicine, focusing on early diagnosis and rapid translation of scientific discoveries to clinical practice.
Supported by media partner Nature Publishing Group and technology founders Agilent Technologies, GE Healthcare and Life Technologies, the WIN Symposium aims to develop greater collaboration in the scientific community, both academic and industrial. The WIN Symposium’s innovative approach has been endorsed by numerous academic institutions and oncology organizations around the world – including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Organisation of European Cancer Institutes (OECI) – as well as sponsorship from the National Breast Cancer Foundation, Inc. and sanofi-aventis.
The program of the WIN Symposium will be dedicated to early diagnosis, personalized medicine and the future of oncology care, and will give participants the chance to discuss this complex issue with key opinion leaders, in an open and interactive forum. The WIN Symposium has been accredited with 17 ESMO-MORA category 1 points.
© 2000 - 2022 Al Bawaba (www.albawaba.com)